Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CERE | Common Stock | Options Exercise | $193K | +55K | $3.50* | 55K | Nov 10, 2021 | Direct | F1 | |
transaction | CERE | Common Stock | Sale | -$912K | -23.6K | -42.97% | $38.59 | 31.4K | Nov 10, 2021 | Direct | F1, F2 |
transaction | CERE | Common Stock | Sale | -$243K | -6.14K | -19.56% | $39.61 | 25.2K | Nov 10, 2021 | Direct | F1, F3 |
transaction | CERE | Common Stock | Sale | -$405K | -10K | -39.75% | $40.41 | 15.2K | Nov 10, 2021 | Direct | F1, F4 |
transaction | CERE | Common Stock | Sale | -$544K | -13.1K | -86.43% | $41.44 | 2.06K | Nov 10, 2021 | Direct | F1, F5 |
transaction | CERE | Common Stock | Sale | -$87.4K | -2.06K | -100% | $42.37 | 0 | Nov 10, 2021 | Direct | F1, F6 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CERE | Stock Option (Right to Buy) | Options Exercise | $0 | -55K | -11.44% | $0.00 | 426K | Nov 10, 2021 | Common Stock | 55K | $3.50 | Direct | F1, F7 |
Id | Content |
---|---|
F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated October 8, 2021 adopted by the Reporting Person. |
F2 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.06 to $38.85 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F3 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.135 to $40.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F4 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.15 to $40.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F5 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.17 to $41.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F6 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.26 to $43.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F7 | 25% of the shares subject to this option vested and became exercisable on April 8, 2020, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. |